| 货号 | HY422046 |
|---|
| 产品名称 | Research Grade Acazicolcept |
|---|
| 中文品名/别名 | ALPN-101, ICOSLvIgD-Fc, 2270247-50-0 |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | Human |
|---|
| 应用实验 | ELISA, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | CD28, TP44, T-cell-specific surface glycoprotein CD28, CD278, ICOS, Inducible T-cell costimulator, Activation-inducible lymphocyte immunomediatory molecule, AILIM |
|---|
| 基因号 | P10747 & Q9Y6W8 |
|---|
| 宿主/表达体系 | Mammalian Cells |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Acazicolcept ( HY422046 ) is a research-grade recombinant antibody targeting CD28 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|